Drug delivery endovascular stent and method of use
An improvement in drug-eluting stents, and method of their making, are disclosed. The surface of a metal stent is roughened to have a surface roughness of at least about 20 μin (0.5 μm) and a surface roughness range of between about 300-700 μin (7.5-17.5 μm). The roughened stent surface is covered with a polymer-free coating of a limus drug, to a coating thickness greater than the range of surface roughness of the roughened stent surface.
1. An expandable stent for use in reducing the rate of occurrence and/or extent of restenosis or thrombosis, comprising:
an expandable stent body formed of interconnected metal filaments,
formed on outer surface regions of the filaments a roughened stent surface characterized by a surface roughness (Ra) of between 20-40 μin (0.5 to 1 μm), and a surface roughness range (Rt) of between 300-700 μin (7.5-17.5 μm), and
carried on the roughened stent surface of the filaments is a polymer-free limus drug coating having a coating thickness greater than the surface roughness range (Rt) of the roughened stent surface.
2. The stent according to claim 1 , wherein the surface roughness range (Rt) is between 300-500 μin (7.5-12.5 μm).
3. The stent according to claim 1 , wherein a limus drug within the polymer free limus drug coating is 42-O-ethoxyethyl rapamycin.
4. The stent according to claim 1 , wherein the polymer-free limus drug coating carries between 80 to 240 ug/cm stent length.
5. The stent according to claim 1 , wherein the polymer-free limus drug coating has a thickness between 5 and 15 μm.